Curbing the tuberculosis and diabetes co-epidemic
Bao, J., Hafner, R., Lin, Y., Lin, H.H. and Magee, M.J., 2018. Curbing the tuberculosis and diabetes co-epidemic: strategies for the integration of clinical care and research. The International Journal of Tuberculosis and Lung Disease, 22(10), pp.1111-1112.
Progress in reducing TB incidence and mortality has been slow. TB control strategies are being threatened by diabetes mellitus (DM), a non-communicable disease. DM increases the risk of developing active TB. The prevalence of DM has risen most quickly in low- and middle-income regions with significant TB burdens. Current estimates suggest DM contributes to as many cases of active TB as HIV/AIDS. The DM epidemic continues to increase steadily. Patients with both TB and DM experience worse clinical outcomes, including increased risk of treatment failure, relapse, and death. Resources for TB-DM research and treatment programs are limited. Large-scale clinical trials have not been conducted to find better treatment and management methods for patients with concurrent TB and DM.
Comments
Post a Comment